News
The Canadian government is currently considering approving the entry of gene-edited pigs into the food system.
ARK Innovation ETF (BATS: ARKK) is pushing to fresh 52-week highs Thursday, buoyed by strong performances from its key ...
Analysts have also weighed in on stock throughout the month. Recent analyst calls on the stock include: Needham analyst Gil ...
Additionally, investors may have begun repositioning portfolios ahead of the release of second-quarter earnings results.
1d
Zacks Investment Research on MSNCRISPR Therapeutics (CRSP) Moves 9.6% Higher: Will This Strength Last?CRISPR Therapeutics AG CRSP shares rallied 9.6% in the last trading session to close at $60.08. This move can be attributable to notable volume with a higher number of shares being traded than in a ...
CZI and the IGI announce the funding of the Center for Pediatric CRISPR Cures to use CRISPR-based editing technology to advance cures.
Names including Kohls, Plug Power, and Mara Holdings round out the list of the market's top 10 most-shorted stocks.
Vertex Pharmaceuticals Incorporated remains a top Buy with a strong cystic fibrosis franchise, innovative pipeline, and cell therapies. Click for my VRTX update.
1d
AZoLifeSciences on MSNNew Software Boosts Genome Editing Accuracy for Genetic TherapiesThis innovative software, CRISPRware, optimizes guide RNA design for genome editing, supporting research on genetic disorders ...
A Ph.D. student in biomolecular engineering at the University of California, Santa Cruz, has built a software program ...
KJ Muldoon recently made history by becoming the first patient to receive a personalized CRISPR gene therapy, designed specifically for the genetic mutations causing his rare metabolic disease. | KJ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results